About
The Idea
The Concept
Strategy
Opportunity
The Need
The Market
The Unique Concept
The Competition
Scientific Foundation
Knowledge Platform
Modes of Action
Results
IPR
Publications
Team
News
Contact
unnamed
Home
News
Phase I Study Results of a Novel Immunomodulatory Peptide, TCP-25, for Treatment of Dystrophic Epidermolysis Bullosa
unnamed